Method for treating thrombocytopenia
Patent Number: 5126325
Date of First Priority Issue: Friday January 13th, 1989
Date Issued: Tuesday June 30th, 1992
Assignee: Ajinomoto Co., Inc. (Tokyo, JP); Kishimoto, Tadamitsu (Tondabayashi, JP)
Inventors: Kishimoto, Tadamitsu (Tondabayashi-shi, Osaka-fu, JP); Hirano, Toshio (Ibaraki, JP); Kimura, Hideo (Fukushima, JP); Ishibashi, Toshiyuki (Fukushima, JP); Akiyama, Yukio (Kawasaki, JP); Okano, Akira (Kawasaki, JP)
From Class: Differentiation
Comments: No comments
This patent covers the use of B cell differentiation factor (BCDF) for treatment of thrombocytopenia. This may be interesting if the BCDF is still not characterized. It may be an interesting new way of stimulating hematpoietic stem cells to preferentially go towards the path of a specific lineage. I do have a feeling, however that the BCDF is actually IL-6.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.